The San Francisco-based startup, which closed a $5 million Series A round in 2017, aims to develop nutritionally enhanced food and feed crops.
The collaborators will grant the licenses to any entities wanting to use the technology for commercial agricultural research and product development.
Agricultural companies are thinking about how to get consumers comfortable with gene-edited crops, the Wall Street Journal says.
DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications.
The company said its acquisition of DuPont Diagnostics will allow it to provide a broader array of food safety diagnostics services to its customers.
DuPont Pioneer has entered into a collaboration to apply CRISPR genome editing to the development of crop varieties for farmers in developing countries.
DuPont Pioneer researchers used a CRISPR genome editing approach to develop corn that appears to be more drought tolerant.
The firms also renewed distribution agreements for DuPont's BAX System Q7 food safety testing platform in Canada, Australia and New Zealand.
The in vitro assay enabled the scientists to take an uncharacterized Cas9 variant from Brevibacillus laterosporus and edit maize cells with it.
DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.
The New York Times Magazine examines gender discrimination at the Salk Institute.
Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.
A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.